{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:09:50Z","timestamp":1794006590496,"version":"4.8.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006939","name":"Emory University","doi-asserted-by":"publisher","award":["Medicines360"],"award-info":[{"award-number":["Medicines360"]}],"id":[{"id":"10.13039\/100006939","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023918","name":"Department of Obstetrics and Gynecology, Weill Cornell Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023918","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ajog.2024.06.049","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T06:43:34Z","timestamp":1719989014000},"page":"628.e1-628.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hormone-related side effects in new users of a levonorgestrel 52-mg intrauterine device"],"prefix":"10.1016","volume":"231","author":[{"given":"Jennifer L.","family":"Kerns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Keder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie A.","family":"Cwiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn L.","family":"Westhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5967-8180","authenticated-orcid":false,"given":"Mitchell D.","family":"Creinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2024.06.049_bib1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/13625187.2020.1815008","article-title":"Comparative pharmacokinetic analysis of levonorgestrel-releasing intrauterine systems and levonorgestrel-containing contraceptives with oral or subdermal administration route","volume":"25","author":"Hofmann","year":"2020","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2024.06.049_bib2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.fertnstert.2011.12.003","article-title":"A\u00a0randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena","volume":"97","author":"Gemzell-Danielsson","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.06.049_bib3","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0000000000000019","article-title":"Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial","volume":"122","author":"Nelson","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.06.049_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.contraception.2015.04.006","article-title":"Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system","volume":"92","author":"Eisenberg","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.06.049_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/AOG.0000000000003034","article-title":"Five-year contraceptive efficacy and safety of a levonorgestrel 52-mg intrauterine system","volume":"133","author":"Teal","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.06.049_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.contraception.2019.10.010","article-title":"Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system","volume":"101","author":"Westhoff","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.06.049_bib7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.06.049_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejogrb.2010.12.027","article-title":"Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 \u03bcg plus drospirenone 3mg administered in a 24\/4 regimen: a pooled analysis","volume":"155","author":"Koltun","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2024.06.049_bib9","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1097\/AOG.0000000000003880","article-title":"Influence of contraception class on incidence and severity of acne vulgaris","volume":"135","author":"Barbieri","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.06.049_bib10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/09513590.2021.1993813","article-title":"Female sexual function in women using LARC methods","volume":"38","author":"Trigo","year":"2022","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.06.049_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.srhc.2019.06.007","article-title":"A\u00a0survey of young women's perceptions of the influence of the levonorgestrel-intrauterine system or copper-intrauterine device on sexual desire","volume":"21","author":"Malmborg","year":"2019","journal-title":"Sex Reprod Healthc"},{"key":"10.1016\/j.ajog.2024.06.049_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.contraception.2016.11.006","article-title":"Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome","volume":"95","author":"Brooks","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.06.049_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13785","article-title":"Contraceptive effects on the cervicovaginal microbiome: recent evidence including randomized trials","volume":"90","author":"Balle","year":"2023","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2024.06.049_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.contraception.2017.10.005","article-title":"Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use","volume":"97","author":"Darney","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2024.06.049_bib15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/13625187.2018.1449825","article-title":"Bleeding patterns for the Liletta\u00ae levonorgestrel 52 mg intrauterine system","volume":"23","author":"Schreiber","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2024.06.049_bib16","doi-asserted-by":"crossref","first-page":"S888.e1","DOI":"10.1016\/j.ajog.2019.11.1288","article-title":"Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding","volume":"222","author":"Chen","year":"2020","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824007439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824007439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T22:33:32Z","timestamp":1732142012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937824007439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0002937824007439"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2024.06.049","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormone-related side effects in new users of a levonorgestrel 52-mg intrauterine device","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2024.06.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}